When it just won't go away: oral artemisinin monotherapy in Nigeria, threatening lives, threatening progress

<p>BACKGROUND: Oral artemisinin monotherapy (AMT), an important contributor to multi-drug resistant malaria, has been banned in Nigeria. While oral AMT has scarcely been found for several years now in other malaria-endemic countries, availability has persisted in Nigeria&amp;apos;s private...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: ACTwatch Group, Ujuju, C, Anyanti, J, Newton, PN, Ntadom, G
Formatua: Journal article
Hizkuntza:English
Argitaratua: BioMed Central 2017

Antzeko izenburuak